Lupin partners with AbbVie to develop, commercialise novel oncology drug

Additionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the programme in India, the company added.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2V603fr
via IFTTT